Indapamide
Showing 1 - 25 of 72
Kidney Stone Trial in Bern (Indapamide 2.5 MG, Hydrochlorothiazide 50Mg, Chlorthalidone 25mg)
Not yet recruiting
- Kidney Stone
- Indapamide 2.5 MG
- +2 more
-
Bern, SwitzerlandInselspital, Department of Nephrology and Hypertension
Oct 26, 2023
Bioequivalence Trial in Moscow (Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg
Recruiting
- Bioequivalence
- Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet
-
Moscow, Russian FederationLigand Research LLC
Jul 7, 2023
Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets,
Completed
- Bioequivalence
- Healthy Subjects
- PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets
- Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets
-
Amman, JordanInternational Pharmaceutical Research Center
Jul 18, 2022
Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg
Completed
- Bioequivalence
- Healthy Subjects
- PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
- TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets
-
Amman, JordanInternational Pharmaceutical Research Center
Jul 20, 2022
Pharmacogenomics Trial (Indapamide 1.5 MG SR)
Not yet recruiting
- Pharmacogenomics
- Indapamide 1.5 MG SR
- (no location specified)
Mar 15, 2022
Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Hydroxychloroquine Pill
- Indapamide Pill
-
Calgary, Alberta, CanadaFoothills Medical Centre
May 16, 2022
Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan
Not yet recruiting
- Hypertension
- Hypertension,Essential
- fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
- Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
- (no location specified)
Mar 17, 2022
Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )
Recruiting
- Essential Hypertension
- Fimasartan + Indapamide
- Fimasartan + Indapamide placebo
-
Bucheon-si, Kyunggi-do, Korea, Republic ofThe Catholic University of Korea, Bucheon St.Mary's Hospital
May 18, 2023
Primary Hypertension Trial in India (Amlodipine + Perindopril, Perindopril + Indapamide, Amlodipine + Indapamide)
Recruiting
- Primary Hypertension
- Amlodipine + Perindopril
- +2 more
-
Guntur, Andhra Pradesh, India
- +13 more
Jan 12, 2023
Hypertension Trial in China (Fixed [Per/Ind/Aml], Free [Per/Ind + Aml])
Completed
- Hypertension
- Fixed [Per/Ind/Aml]
- Free [Per/Ind + Aml]
-
Beijing, Beijing, China
- +41 more
Apr 18, 2023
Hypertension Trial in Australia, United States (Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20
Recruiting
- Hypertension
- Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg
- +2 more
-
Tampa, FloridaPrecision Research Center
Dec 13, 2021
Hypertension Trial in Gyeonggi-do (BR1015-1, BR1015-2, BR1015-1 + BR1015-2)
Completed
- Hypertension
- BR1015-1
- +2 more
-
Gyeonggi-do, Seongnam-si, Korea, Republic ofCHA Bundang Medical Center, CHA University
Nov 18, 2021
Calcium Phosphate Kidney Stones Trial in Dallas (Placebo, Citric Acid, Potassium Citrate)
Recruiting
- Calcium Phosphate Kidney Stones
- Placebo
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Jan 27, 2022
Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5
Recruiting
- Hypertension
- Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
- +7 more
-
Phoenix, Arizona
- +84 more
Aug 19, 2022
Arterial Hypertension Trial (LENINGRADO 5 association, Natrilix® SR, Natrilix SR Placebo)
Withdrawn
- Arterial Hypertension
- LENINGRADO 5 association
- +3 more
- (no location specified)
Feb 22, 2021
Stroke, Cerebral Small Vessel Diseases, Intracerebral Hemorrhage Trial in Liverpool, Birtinya, Melbourne (telmisartan 20 mg +
Terminated
- Stroke
- +4 more
- telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg
- Placebo oral capsule
-
Liverpool, New South Wales, Australia
- +2 more
May 24, 2021
Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular Trial in Australia, Netherlands (telmisartan 20mg + amlodipine
Terminated
- Cognitive Decline
- +5 more
- telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg
- Placebo oral capsule
-
Liverpool, New South Wales, Australia
- +3 more
Mar 29, 2021
Hypertension Trial in Beijing (Spironolactone, Indapamide, Amlodipine)
Unknown status
- Hypertension
- Spironolactone
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Dec 1, 2019
Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)
Recruiting
- Resistant Arterial Hypertension
- Blood samples will be taken for pharmacokinetics and pharmacogenetics
-
Ryazan, Russian FederationRyzan State Medical University
Jun 1, 2023
Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)
Suspended
- Hypertension
- COVID-19
- Thiazide or Thiazide-like diuretics
- +3 more
-
Galway, IrelandUniversity Hospital Galway
Jun 26, 2020
TrIple Fixed-dose Combination in Treatment of Arterial
Completed
- Arterial Hypertension
- amlodipine / indapamide / perindopril arginine FDC
-
Almetyevsk, Russian Federation
- +50 more
May 27, 2021
Blood Pressure Variability Trial (Low BPV Regimen)
Not yet recruiting
- Blood Pressure Variability
- Low BPV Regimen
- (no location specified)
Aug 23, 2023